HomeCompareFAAS vs MRK

FAAS vs MRK: Dividend Comparison 2026

FAAS yields 2469.14% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FAAS wins by $71690433869.04M in total portfolio value
10 years
FAAS
FAAS
● Live price
2469.14%
Share price
$0.08
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$71690433869.09M
Annual income
$66,400,343,104,095,020.00
Full FAAS calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — FAAS vs MRK

📍 FAAS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFAASMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FAAS + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FAAS pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FAAS
Annual income on $10K today (after 15% tax)
$209,876.54/yr
After 10yr DRIP, annual income (after tax)
$56,440,291,638,480,770.00/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, FAAS beats the other by $56,440,291,638,472,170.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FAAS + MRK for your $10,000?

FAAS: 50%MRK: 50%
100% MRK50/50100% FAAS
Portfolio after 10yr
$35845216934.58M
Annual income
$33,200,171,552,052,570.00/yr
Blended yield
92.62%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

FAAS
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
-0.7
Piotroski
3/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FAAS buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFAASMRK
Forward yield2469.14%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$71690433869.09M$57.7K
Annual income after 10y$66,400,343,104,095,020.00$10,113.78
Total dividends collected$71320494496.27M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: FAAS vs MRK ($10,000, DRIP)

YearFAAS PortfolioFAAS Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$257,614$246,913.58$11,213$373.04+$246.4KFAAS
2$6,220,347$5,944,700.13$12,667$512.06+$6.21MFAAS
3$140,806,183$134,150,411.83$14,439$708.14+$140.79MFAAS
4$2,988,682,073$2,838,019,457.81$16,640$988.16+$2988.67MFAAS
5$59,495,451,401$56,297,561,582.68$19,432$1,394.07+$59495.43MFAAS
6$1,111,053,579,695$1,047,393,446,695.76$23,057$1,992.90+$1111053.56MFAAS
7$19,468,874,566,651$18,280,047,236,377.10$27,889$2,894.79+$19468874.54MFAAS
8$320,195,562,728,668$299,363,866,942,351.70$34,518$4,286.29+$320195562.69MFAAS
9$4,944,010,060,747,097$4,601,400,808,627,422.00$43,912$6,494.35+$4944010060.70MFAAS
10$71,690,433,869,094,420$66,400,343,104,095,020.00$57,714$10,113.78+$71690433869.04MFAAS

FAAS vs MRK: Complete Analysis 2026

FAASStock

DigiAsia Corp. develops an AI embedded finance platform in Southeast Asia. It offers B2B fintech platform for bill payments, supply chain payments, and branchless banking solutions for merchants, partners, and customers; digital wallets; QRIS Payment as a Service; Cash Management system for ERP system that allows users to create a closed-loop cash management system; Digital Product & Billers, which allows users to purchase digital products or pay bills to multiple issuers or billers; and Remittance Product that enables users to transfer funds from their application cash-to-cash, cash-to-account, account-to-cash, and account-to-account. The company also provides B2B Loan product for micro, small, and medium enterprises; Gold saving products; Virtual Card Number to generate a digital invoice for customers to accept payment over internet transactions; Buy Now Pay Later; e-KYC module to Onboard new customers securely in compliance with regulation; Cash in & Cash Out points; KasPro Bank for Banks and FSI to utilize their networks of retail outlets onboarded as licensed digital banking agents to offer cash-in & cash-out points to serve micro small, and medium enterprises. DigiAsia Corp. is headquartered in Jakarta, Indonesia.

Full FAAS Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this FAAS vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FAAS vs SCHDFAAS vs JEPIFAAS vs OFAAS vs KOFAAS vs MAINFAAS vs JNJFAAS vs ABBVFAAS vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.